SCM
BBNX

Sterling Capital Management’s Beta Bionics BBNX Stock Holding History

Sterling Capital Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9K Buy
821
+443
+117% +$5.27K ﹤0.01% 2094
2026
Q1 		$3.79K Sell
378
-122
-24% -$1.8K ﹤0.01% 2828
2025
Q4 		$15.2K Buy
500
+95
+23% +$2.54K ﹤0.01% 2381
2025
Q3 		$8.05K Buy
405
+341
+533% +$5.99K ﹤0.01% 2608
2025
Q2 		$932 Sell
64
-21
-25% -$297 ﹤0.01% 3071
2025
Q1 		$1.04K Buy
+85
New +$1.58K ﹤0.01% 2800

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Sterling Capital Management's BBNX Position: Q2 2026 in Review

Sterling Capital Management increased its Beta Bionics (BBNX) stake by 117% in Q2 2026, buying an estimated $5.27K and bringing the position to 821 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2094.

Sterling Capital Management first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $15.2K in Q4 2025. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Sterling Capital Management held 821 shares of Beta Bionics worth $12.9K as of Q2 2026.
  • Sterling Capital Management bought 443 Beta Bionics shares in Q2 2026, an estimated $5.27K.
  • Beta Bionics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2094 holding.
  • Sterling Capital Management first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • Sterling Capital Management's Beta Bionics position peaked at $15.2K in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.